Grifols S.A. (GRF) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.020x

Based on the latest financial reports, Grifols S.A. (GRF) has a cash flow conversion efficiency ratio of 0.020x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€155.27 Million ≈ $181.52 Million USD) by net assets (€7.60 Billion ≈ $8.88 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Grifols S.A. to measure how much of total assets are equity-financed.

Grifols S.A. - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how Grifols S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check GRF cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Grifols S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Grifols S.A. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Spirit Aerosystems Holdings Inc NYSE:SPR	0.041x
Isupetasys KO:007660	0.066x
Ajanta Pharma Limited NSE:AJANTPHARM	0.066x
COCHLEAR LTD ADR 1/2/O.N. F:OC50	N/A
Sotera Health Co NASDAQ:SHC	0.047x
China National Software & Service Co Ltd SHG:600536	-0.017x
AP Memory Technology Corp TW:6531	0.051x
Blue Owl Technology Finance Corp. NYSE:OTF	0.020x

Annual Cash Flow Conversion Efficiency for Grifols S.A. (2005–2024)

The table below shows the annual cash flow conversion efficiency of Grifols S.A. from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see Grifols S.A. market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€8.61 Billion ≈ $10.06 Billion	€902.17 Million ≈ $1.05 Billion	0.105x	+301.21%
2023-12-31	€7.97 Billion ≈ $9.32 Billion	€208.28 Million ≈ $243.50 Million	0.026x	+2133.27%
2022-12-31	€8.46 Billion ≈ $9.89 Billion	€-10.87 Million ≈ $-12.70 Million	-0.001x	-101.75%
2021-12-31	€8.15 Billion ≈ $9.52 Billion	€596.98 Million ≈ $697.93 Million	0.073x	-55.65%
2020-12-31	€6.72 Billion ≈ $7.86 Billion	€1.11 Billion ≈ $1.30 Billion	0.165x	+98.81%
2019-12-31	€6.85 Billion ≈ $8.00 Billion	€568.93 Million ≈ $665.14 Million	0.083x	-47.07%
2018-12-31	€4.70 Billion ≈ $5.49 Billion	€737.43 Million ≈ $862.13 Million	0.157x	-32.21%
2017-12-31	€3.63 Billion ≈ $4.25 Billion	€841.75 Million ≈ $984.09 Million	0.232x	+56.07%
2016-12-31	€3.73 Billion ≈ $4.36 Billion	€553.28 Million ≈ $646.84 Million	0.148x	-34.04%
2015-12-31	€3.30 Billion ≈ $3.86 Billion	€742.78 Million ≈ $868.39 Million	0.225x	-38.80%
2014-12-31	€2.66 Billion ≈ $3.11 Billion	€978.93 Million ≈ $1.14 Billion	0.368x	+30.85%
2013-12-31	€2.11 Billion ≈ $2.46 Billion	€592.01 Million ≈ $692.12 Million	0.281x	+4.19%
2012-12-31	€1.88 Billion ≈ $2.20 Billion	€507.12 Million ≈ $592.87 Million	0.270x	+103.85%
2011-12-31	€1.66 Billion ≈ $1.95 Billion	€220.23 Million ≈ $257.47 Million	0.132x	-10.25%
2010-12-31	€707.39 Million ≈ $827.01 Million	€104.25 Million ≈ $121.88 Million	0.147x	-3.31%
2009-12-31	€578.53 Million ≈ $676.36 Million	€88.18 Million ≈ $103.09 Million	0.152x	-0.07%
2008-12-31	€481.28 Million ≈ $562.67 Million	€73.41 Million ≈ $85.82 Million	0.153x	-33.90%
2007-12-31	€384.17 Million ≈ $449.13 Million	€88.64 Million ≈ $103.63 Million	0.231x	+73.19%
2006-12-31	€368.35 Million ≈ $430.64 Million	€49.08 Million ≈ $57.38 Million	0.133x	-93.77%
2005-12-31	€55.95 Million ≈ $65.41 Million	€119.72 Million ≈ $139.97 Million	2.140x	--

About Grifols S.A.

MC:GRF Spain Drug Manufacturers - General

Market Cap

$4.64 Billion

€3.97 Billion EUR

Market Cap Rank

#3717 Global

#30 in Spain

Share Price

€9.40

Change (1 day)

-3.49%

52-Week Range

€8.67 - €13.52

All Time High

€33.56